PTC Therapeutics Statistics
Total Valuation
PTCT has a market cap or net worth of $6.20 billion. The enterprise value is $6.99 billion.
Important Dates
The next estimated earnings date is Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTCT has 80.29 million shares outstanding. The number of shares has increased by 10.56% in one year.
| Current Share Class | 80.29M |
| Shares Outstanding | 80.29M |
| Shares Change (YoY) | +10.56% |
| Shares Change (QoQ) | +11.47% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 100.21% |
| Float | 70.56M |
Valuation Ratios
The trailing PE ratio is 8.64.
| PE Ratio | 8.64 |
| Forward PE | n/a |
| PS Ratio | 3.38 |
| Forward PS | 6.77 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.80 |
| P/OCF Ratio | 8.67 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.32, with an EV/FCF ratio of 9.91.
| EV / Earnings | 9.30 |
| EV / Sales | 3.93 |
| EV / EBITDA | 7.32 |
| EV / EBIT | 7.58 |
| EV / FCF | 9.91 |
Financial Position
The company has a current ratio of 2.32
| Current Ratio | 2.32 |
| Quick Ratio | 2.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.55 |
| Debt / FCF | 3.53 |
| Interest Coverage | 5.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 25.70% |
| Return on Invested Capital (ROIC) | 30.63% |
| Return on Capital Employed (ROCE) | 51.89% |
| Revenue Per Employee | $1.89M |
| Profits Per Employee | $800,557 |
| Employee Count | 939 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 11.39 |
Taxes
| Income Tax | -10.72M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.72% in the last 52 weeks. The beta is 0.49, so PTCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +68.72% |
| 50-Day Moving Average | 75.48 |
| 200-Day Moving Average | 57.82 |
| Relative Strength Index (RSI) | 53.05 |
| Average Volume (20 Days) | 1,152,069 |
Short Selling Information
The latest short interest is 11.44 million, so 14.25% of the outstanding shares have been sold short.
| Short Interest | 11.44M |
| Short Previous Month | 12.86M |
| Short % of Shares Out | 14.25% |
| Short % of Float | 16.22% |
| Short Ratio (days to cover) | 5.04 |
Income Statement
In the last 12 months, PTCT had revenue of $1.78 billion and earned $751.72 million in profits. Earnings per share was $8.94.
| Revenue | 1.78B |
| Gross Profit | 1.28B |
| Operating Income | 922.26M |
| Pretax Income | 741.00M |
| Net Income | 751.72M |
| EBITDA | 954.94M |
| EBIT | 922.26M |
| Earnings Per Share (EPS) | $8.94 |
Full Income StatementBalance Sheet
The company has $1.71 billion in cash and $2.49 billion in debt, with a net cash position of -$784.74 million or -$9.77 per share.
| Cash & Cash Equivalents | 1.71B |
| Total Debt | 2.49B |
| Net Cash | -784.74M |
| Net Cash Per Share | -$9.77 |
| Equity (Book Value) | -155.76M |
| Book Value Per Share | -1.95 |
| Working Capital | 1.14B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $715.47 million and capital expenditures -$10.25 million, giving a free cash flow of $705.21 million.
| Operating Cash Flow | 715.47M |
| Capital Expenditures | -10.25M |
| Free Cash Flow | 705.21M |
| FCF Per Share | $8.78 |
Full Cash Flow StatementMargins
Gross margin is 71.71%, with operating and profit margins of 51.84% and 42.25%.
| Gross Margin | 71.71% |
| Operating Margin | 51.84% |
| Pretax Margin | 41.65% |
| Profit Margin | 42.25% |
| EBITDA Margin | 53.67% |
| EBIT Margin | 51.84% |
| FCF Margin | 39.64% |
Dividends & Yields
PTCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.56% |
| Shareholder Yield | -10.56% |
| Earnings Yield | 12.12% |
| FCF Yield | 11.37% |
Dividend DetailsAnalyst Forecast
The average price target for PTCT is $73.76, which is -4.51% lower than the current price. The consensus rating is "Buy".
| Price Target | $73.76 |
| Price Target Difference | -4.51% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 16.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTCT has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 7 |
